-transparent.png){kind=logo}
Bone marrow granulomas and neutropenia occurred in a 77-year-old man following the ingestion of procainamide hydrochloride for 50 days. Although neutropenia has occasionally occurred following procainamide therapy, granulomas in the bone marrow have not previously been associated with the use of this drug. There was no other apparent agent that could have been responsible for the granulomas. Eighteen days after administration of the drug had been discontinued, the WBC count returned to normal and there were no granulomas present in the bone marrow.
Related Publications
J Riker, and
J Baker, and
M Swanson
May 1985,
New York state journal of medicine,
J Riker, and
J Baker, and
M Swanson
January 2019,
Reumatologia clinica,
J Riker, and
J Baker, and
M Swanson
November 1979,
Clinical immunology and immunopathology,
J Riker, and
J Baker, and
M Swanson
June 1992,
Southern medical journal,
J Riker, and
J Baker, and
M Swanson
July 2000,
Pharmacotherapy,
J Riker, and
J Baker, and
M Swanson
May 2017,
Revista medica de Chile,
J Riker, and
J Baker, and
M Swanson
April 2003,
The International journal of eating disorders,
J Riker, and
J Baker, and
M Swanson
February 1984,
Annals of internal medicine,
J Riker, and
J Baker, and
M Swanson
July 2013,
Blood,
J Riker, and
J Baker, and
M Swanson
August 1990,
Israel journal of medical sciences,
